What this covers

Sally Satel, a psychiatrist and resident scholar at the American Enterprise Institute who has herself received two kidney donations, speaks with Russ Roberts about the chronic shortage of transplantable organs and how policy might close the gap between supply and demand. The conversation centers on a specific proposal: a non-cash federal incentive—such as a refundable tax credit of $5,000 yearly for up to ten years—designed to reward kidney donors while avoiding the immediate liquidity that might lead to regret. Satel lays out the scope of the shortage (roughly 98,000 people waiting, only 18,000 transplants yearly, twelve deaths daily) and argues that altruism alone has proven insufficient. She frames this as a solvable policy problem, not a moral impasse.

The discussion moves through the ethical objections that have blocked compensation in the United States. Satel distinguishes between coercion, ordinary inducement, and undue inducement—arguing that critics often misapply the language of coercion and that exploitation thrives in the existing black market precisely because it lacks legal structure and safeguards. A central tension emerges: surgeons, procurement organizations, and Medicare already profit substantially from transplantation, yet compensating the donor—the person who bears the physical risk—is deemed unethical. The comparison to college athletics, where coaches earn millions while athletes generating that value receive nothing, sharpens the inconsistency. Satel also touches on how family dynamics often prove decisive in whether a potential donor proceeds, on the grinding reality of dialysis, and on technological futures—3D-printed organs and transgenic pigs—that may render the entire question moot within decades. Throughout, she notes that the public supports compensation more readily than the transplant establishment does.

Sharpest takeaway

Satel argues the chronic shortage of transplantable kidneys is a policy failure that could be solved by rewarding donors through a carefully structured, non-cash, government-administered incentive (such as a refundable tax credit), and that the ethical objections of commodification, exploitation, and coercion are mostly ill-defined and refuted by the very surgeons and systems that already profit from transplantation.

  • Twelve people die daily and ~98,000 wait for kidneys while only ~18,000 transplants occur yearly, proving altruism alone is insufficient.
  • A structured incentive (delayed, in-kind, third-party-administered) avoids the regret/exploitation problems critics fear, unlike a cash black market.
  • Surgeons, procurement organizations, and Medicare already commodify the process, undermining the moral objection to compensating donors.

The argument · threads3 threads · 24 claims
0.85

Prohibiting donor payment while paying surgeons and procurement organizations is inconsistent commodification that undervalues the donor's risk and contribution.

2 pointscentrality 5/5
  • The prohibition on paying donors parallels the NCAA's ban on paying college athletes: just as coaches like Nick Saban earn millions while athletes generating that value are paid nothing on the grounds it would 'demean' them or harm education, transplant surgeons earn large sums while it is considered demeaning to reward the donors whose organs make the surgery possible.

    “Nick Saban can make millions of dollars a year... it is considered demeaning to them that they would be paid... So, these surgeons and doctors... make hundreds of thousands, and sometimes millions of dollars transplanting kidneys... and would be offended if somehow people made as much money as they did.”

  • It is inconsistent that surgeons, nephrologists, and Organ Procurement Organizations all receive cash (e.g. ~$50,000 to procure and transfer a deceased organ) for transplantation, yet the one person who takes the real risk and gives the thing of value--the donor--is forbidden from being rewarded; the surgeon's paid service is itself a form of commodification that no one objects to.

    “Nick Saban can make millions of dollars a year... it is considered demeaning to them that they would be paid... So, these surgeons and doctors... make hundreds of thousands, and sometimes millions of dollars transplanting kidneys... and would be offended if somehow people made as much money as they did.”

0.70

Financial incentives and altruistic motives can coexist in organ donation rather than excluding each other.

1 pointcentrality 5/5
  • Financial incentives can motivate organ donors while coexisting with intrinsic, altruistic motives; the financial and humanitarian dimensions intermingle rather than crowd each other out, and it is a mistake to treat them as mutually exclusive.

    “money certainly motivates people; it's not the only thing that motivates people... they can certainly co-exist with those other motives... I don't see any reason why those things are exclusive, and I think it's a terrible mistake to think that they are.”

0.56

Crowding out of altruistic donors by compensation is an empirical problem solvable by adjusting price to attract sufficient new donors.

1 pointcentrality 4/5
  • Even if compensation crowds out some altruistic donors who only gave for moral satisfaction, this is an empirical and solvable problem: an economist would simply set the price higher to attract enough new donors, so losing a few altruistic givers is more than offset by many willing to donate for compensation.

    “as an economist, it just means you better set the price a little higher than you thought you might have needed to, to overcome--you might lose the... 5000 people who donate right now... And so, now you are going to get as many people as you want to donate out of mercenary motives.”